109
Views
14
CrossRef citations to date
0
Altmetric
Review

Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations

Pages 303-312 | Published online: 27 Feb 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. Valletta, A. R. Santamaria & G. Pasqua. (2007) CPT accumulation in the fruit and during early phases of plant development in Decaisne (Nyssaceae). Natural Product Research 21:14, pages 1248-1255.
Read now

Articles from other publishers (13)

Lijuan Xue, Xingkai Qian, Qiang Jin, Yadi Zhu, Xiaoyu Wang, Dandan Wang, Guangbo Ge & Ling Yang. (2020) Construction and application of a high-content analysis for identifying human carboxylesterase 2 inhibitors in living cell system. Analytical and Bioanalytical Chemistry 412:11, pages 2645-2654.
Crossref
Paul F. Rühle, Nicole Goerig, Roland Wunderlich, Rainer Fietkau, Udo S. Gaipl, Annedore Strnad & Benjamin Frey. (2017) Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression—A Case Report from the IMMO-GLIO-01 Trial. Frontiers in Neurology 8.
Crossref
Takaaki Kodawara, Takashi Higashi, Yutaka Negoro, Yukio Kamitani, Toshiaki Igarashi, Kyohei Watanabe, Hitoshi Tsukamoto, Ryoichi Yano, Mikio Masada, Hiromichi Iwasaki & Toshiaki Nakamura. (2016) The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G. Basic & Clinical Pharmacology & Toxicology 118:5, pages 333-337.
Crossref
Karol Michał Kacprzak. 2013. Natural Products. Natural Products 643 682 .
ChunLei Li, JingXia Cui, CaiXia Wang, YanHui Li, Lan Zhang, Xian Xiu, YongFeng Li, Na Wei, Li Zhang & Ping Wang. (2011) Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation. Journal of Pharmacy and Pharmacology 63:6, pages 765-773.
Crossref
Jamie Horn, Marta Milewska, Susanne M. Arnold & Markos Leggas. (2011) Metabolic Pathways of the Camptothecin Analog AR-67. Drug Metabolism and Disposition 39:4, pages 683-692.
Crossref
Zhe-Yi Hu, Qi Yu & Yuan-Sheng Zhao. (2010) Dose-dependent association between UGT1A1?28 polymorphism and irinotecan-induced diarrhoea: A meta-analysis. European Journal of Cancer 46:10, pages 1856-1865.
Crossref
Supriya Mohile, Nail Nagovskiy & Lodovico Balducci. 2009. Geriatric Oncology. Geriatric Oncology 201 261 .
Richard M. Logan, Rachel J. Gibson, Joanne M. Bowen, Andrea M. Stringer, Stephen T. Sonis & Dorothy M. K. Keefe. (2007) Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemotherapy and Pharmacology 62:1, pages 33-41.
Crossref
Ken-ichi Fujita, Fumio Nagashima, Wataru Yamamoto, Hisashi Endo, Yu Sunakawa, Keishi Yamashita, Hiroo Ishida, Keiko Mizuno, Mototsugu Matsunaga, Kazuhiro Araki, Ryuhei Tanaka, Wataru Ichikawa, Toshimichi Miya, Masaru Narabayashi, Yuko Akiyama, Kaori Kawara, Yuichi Ando & Yasutsuna Sasaki. (2008) Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI). Biological & Pharmaceutical Bulletin 31:11, pages 2137-2142.
Crossref
Howard R. Mellor & Richard Callaghan. (2008) Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response. Pharmacology 81:4, pages 275-300.
Crossref
Richard M. Logan, Andrea M. Stringer, Joanne M. Bowen, Ann S.-J. Yeoh, Rachel J. Gibson, Stephen T. Sonis & Dorothy M.K. Keefe. (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugs. Cancer Treatment Reviews 33:5, pages 448-460.
Crossref
F A de Jong, T J Scott-Horton, D L Kroetz, H L McLeod, L E Friberg, R H Mathijssen, J Verweij, S Marsh & A Sparreboom. (2007) Irinotecan-induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter Protein. Clinical Pharmacology & Therapeutics 81:1, pages 42-49.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.